Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years
NCT ID: NCT01396889
Last Updated: 2011-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2010-05-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Echinacea in Children
NCT00773435
Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections
NCT03812900
Immunologic Effects of Echinacea
NCT00860795
A Trial of Echinacea in Children
NCT00029211
Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants
NCT00611390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Echinacea
0.5ml daily for children 1-2 years old and 2ml daily for children2-5 years old for 3 months
Echinacea
0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old
Placebo
Placebo
Placebo
Placebo (0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old) for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echinacea
0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old
Placebo
Placebo (0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old) for 3 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of hyperactive reactive airway
* using steroid or Echinacea
* chronic pulmonary of cardiac disease
* Acute respiratory disease within one week before study
* Allergic rhinitis
* Allergy to Echinacea
* avoiding to participate in the study
1 Year
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hormozgan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hormozgan University of Medical Sciences (HUMS)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roya Firoozi, Resident
Role: PRINCIPAL_INVESTIGATOR
Hormozgan University of Medical Sciences (HUMS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hormozgan University of Medical Sciences (HUMS)
Bandar Abbas, Hormozgan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Echinacea in URIs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.